Osteotech New Releases




Nov 7, 2008 Osteotech's Next Generation Grafting Material, MagniFuse(TM) Bone Graft, a Breakthrough in Bone Regeneration; MagniFuse(TM) Bone Graft seeks to redefine the standard of care in the U.S. bone graft substitute market estimated to be in excess of $1.2 billio Nov 7, 2008 Osteotech Reports 2008 Third Quarter Financial Results Oct 29, 2008 Osteotech Receives FDA Clearance for its Next Generation Grafting Material Oct 27, 2008 Osteotech Announces Third Quarter Earnings Release and Conference Call Schedule Sep 25, 2008 Cato T. Laurencin, M.D., Ph.D. to Join Osteotech Board of Directors Jul 31, 2008 Osteotech Reports 2008 Second Quarter Diluted Earnings Per Share of $.10 on Revenues of $27.6 Million Jul 29, 2008 Osteotech's Plexur M(TM) Biocomposite Receives FDA Clearance in Spine Jul 24, 2008 Osteotech Announces Second Quarter Earnings Release and Conference Call Schedule May 2, 2008 Osteotech Announces the Unexpected Passing of Audit Committee Member Leads to Receipt of Nasdaq Deficiency Letter May 2, 2008 Osteotech's Plexur(R) Technology to Be Used in Craniofacial Reconstruction Program Funded by the Armed Forces Institute of Regenerative Medicine May 1, 2008 Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10% Apr 30, 2008 Osteotech Engages BioHorizons as Exclusive Distributor to International Dental Market Apr 28, 2008 Osteotech Mourns the Loss of Board Member Robert W. Gunn Apr 25, 2008 Osteotech's Plexur P(TM) Receives FDA Clearance as Bone Void Filler and Bone Graft Extender in Spine Apr 18, 2008 Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance Apr 17, 2008 Osteotech Announces First Quarter Earnings Release and Conference Call Schedule Mar 24, 2008 U.S. Patent Office Confirms Validity of Osteotech's U.S. Patent No. 5,676,146 Mar 24, 2008 Osteotech to Present at the Sidoti Conference in New York Mar 4, 2008 Osteotech Signs Agreement To Distribute Harvest Technologies' BMAC(TM) System Mar 4, 2008 Osteotech Receives FDA Clearance for Plexur M(TM) Biocomposite Mar 3, 2008 Osteotech to Present at the Canaccord Adams' Small-Cap Orthopedics Conference in San Francisco Feb 20, 2008 Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007 Feb 15, 2008 Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule Nov 6, 2007 Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 Oct 30, 2007 Osteotech Announces Third Quarter Earnings Release and Conference Call Schedule Oct 16, 2007 Osteotech Completes Tissue Supply Agreement With LifeNet Health Sep 21, 2007 Osteotech to Present at Sidoti Conference in San Francisco Sep 10, 2007 Osteotech to Present at First Albany Capital's Regenerative Technologies Conference in New York Sep 4, 2007 Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference Aug 1, 2007 Osteotech Reports 2007 Second Quarter Diluted Earnings Per Share of $.05 Jul 25, 2007 Osteotech Announces Second Quarter Earnings Release and Conference Call Schedule May 15, 2007 Osteotech Expands Tissue Supply Relationship With Community Tissue Services May 10, 2007 Osteotech Enters Into Single Source Agreement With Novation May 9, 2007 Osteotech Posts First Quarter Results and Reconfirms 2007 Outlook May 2, 2007 Osteotech Announces First Quarter Earnings Release and Conference Call Schedule Apr 11, 2007 James M. Shannon to Join Osteotech Board of Directors Mar 8, 2007 Osteotech Posts Fourth Quarter Profit and Provides Future Outlook Mar 5, 2007 Osteotech Announces Year End and Fourth Quarter Earnings Release and Conference Call Schedule Feb 13, 2007 Osteotech to Present at First Albany Capital's 2nd Annual Orthopedic Conference Feb 8, 2007 Osteotech Receives FDA Clearance for First Product Under Its Plexus Technology Platform Feb 7, 2007 Osteotech Reports Preliminary 2006 Fourth Quarter Revenues Increased 16% Feb 7, 2007 Osteotech to Present at First Albany and Roth Capital Conferences in February Nov 30, 2006 Osteotech Licenses Patents to Bacterin Nov 3, 2006 Osteotech Reports Third Consecutive Profitable Quarter Oct 26, 2006 Osteotech Announces Third Quarter Earnings Release and Conference Call Schedule Aug 24, 2006 Osteotech Issues Statement Aug 21, 2006 Robert W. Gunn to Join Osteotech Board of Directors Aug 4, 2006 Osteotech Reports 2006 Second Quarter Diluted Earnings Per Share of $.04 on Revenues of $25.3 Million Jul 25, 2006 Osteotech Announces Second Quarter Earnings Release and Conference Call Schedule May 9, 2006 Osteotech Reports 2006 First Quarter Revenues of $25.1 Million and Diluted Earnings Per Share of $.01 May 5, 2006 Osteotech Enters Into Agreement With Premier May 4, 2006 Osteotech Announces First Quarter 2006 Earnings Release and Conference Call Schedule Mar 31, 2006 Osteotech Reports 2005 Full Year and Fourth Quarter Financial Results Mar 28, 2006 Osteotech Announces Year End and Fourth Quarter Earnings Release and Conference Call Schedule Mar 16, 2006 Osteotech Files for Extension of 2005 Annual Report on Form 10-K; Expects to File on or Before March 31, 2006 Mar 1, 2006 Osteotech and Community Tissue Services Enter Into Tissue Supply Agreement Feb 9, 2006 Osteotech Issues Statement Jan 26, 2006 Osteotech to Host Webcast to Discuss Donor Strategy and Technology Pipeline Jan 9, 2006 Osteotech Receives Fifth FDA 510(k) Clearance for Its DBM Product Line Dec 22, 2005 Osteotech Receives FDA Clearance for Majority of Its Family of Grafton(R) DBM Products Dec 20, 2005 Osteotech Receives Its Second FDA Clearance For Its New GraftCage(TM) Product Line, The GraftCage(TM) TLX System Dec 13, 2005 Osteotech's New Product, GraftCage(TM) ACX, Receives FDA Clearance Dec 8, 2005 Osteotech Receives Its Third FDA 510(k) Clearance Dec 5, 2005 Osteotech Receives Its Second Grafton(R) DBM 510(k) FDA Clearance Nov 29, 2005 Osteotech Receives Its First Grafton(R) DBM 510(k) FDA Clearance Nov 23, 2005 Osteotech Announces Executive Management and Board of Director Changes Nov 11, 2005 Osteotech Grafton(R) DBM Family of Products Receives FDA 510(k) Clearance Extension Nov 8, 2005 Osteotech Reports Third Quarter Financial Results; Withdraws 2005 Guidance Nov 3, 2005 Osteotech Announces Third Quarter Earnings Release and Conference Call Schedule Oct 17, 2005 Osteotech Receives Communication From MTF; Withdraws Unsolicited Proposal to Acquire Osteotech Oct 12, 2005 Osteotech Issues Statement Sep 12, 2005 Osteotech to Introduce Two New Products at NASS; Xpanse(TM) Bone Insert and GraftCage(TM) TLX Vertebral Body Replacement Device Sep 1, 2005 MTF Criticized For Its Unwillingness to Recognize Value of Osteotech's Franchise and Its Misleading Statements to Shareholders Aug 31, 2005 Osteotech Introduces New Bio-Implant Product: Graftech(R) Lordotic Cervical Spacer Aug 29, 2005 Osteotech Board of Directors Determines MTF Proposal Inadequate; Unsolicited Proposal Significantly Undervalues the Company and Its Growth Prospects Aug 9, 2005 Osteotech Completes $16.5 Million Sale and Leaseback Transaction Aug 1, 2005 Osteotech Appoints Mark H. Burroughs to Succeed Retiring CFO, Michael J. Jeffries Jul 29, 2005 Osteotech Announces Michael J. Jeffries to Retire Jul 26, 2005 Osteotech Reports Record Second Quarter Revenues; Increases 2005 Revenue Guidance Jul 21, 2005 Osteotech Announces Second Quarter Earnings Release and Conference Call Schedule Jul 15, 2005 Osteotech Engages BDO Seidman, LLP as Independent Registered Public Accounting Firm May 2, 2005 Osteotech Reports First Quarter 2005 Results; Revenues Increase 17% Over Fourth Quarter 2004 Apr 28, 2005 Osteotech Announces First Quarter 2005 Earnings Release and Conference Call Schedule Apr 18, 2005 Osteotech Introduces New Product; Grafton(R) DBM Orthoblend Mar 28, 2005 Osteotech Reports Fourth Quarter 2004 Results; Increases 2005 Earnings Guidance Mar 24, 2005 Osteotech Announces Fourth Quarter 2004 Earnings Release and Conference Call Schedule Mar 16, 2005 Osteotech Files for Extension to File Form 10-K Feb 3, 2005 Osteotech Enters Into License Agreement With Rutgers Advancing Osteotech's Plexus Technology Program Jan 26, 2005 Osteotech Announces Commencement of Second Processing Agreement With MTF and Termination of Processing Agreement With ARC Jan 19, 2005 Osteotech and American Red Cross Enter Into Agreement Terminating Processing Agreement Jan 6, 2005 Osteotech Announces Fourth Quarter 2004 Impairment Charge, Adoption of New Accounting Standard and Initial Guidance for 2005 Dec 28, 2004 Osteotech and MTF Sign a Second Processing Agreement Nov 15, 2004 Osteotech Announces Agreement in Principle With MTF for a Second Processing Agreement Nov 9, 2004 Osteotech Appoints Two New Board Members Oct 25, 2004 Osteotech Reports Profitable Third Quarter 2004 Results; Increases 2004 Earnings Guidance Oct 21, 2004 Osteotech Announces Third Quarter Earnings Release and Conference Call Schedule Sep 20, 2004 Osteotech, Inc. Elects New Senior Vice President, Sales & Marketing Jul 27, 2004 Osteotech, Inc. Reports Second Quarter 2004 Results; Revises Guidance for the Year Jul 22, 2004 Osteotech Announces Second Quarter Earnings Release and Conference Call Schedule Jun 14, 2004 Osteotech Announces Election of New President and Chief Operating Officer Apr 27, 2004 Osteotech, Inc. Reports First Quarter 2004 Results; Performance In Line With Revenue and Earnings Guidance Apr 20, 2004 Osteotech Announces First Quarter Earnings Release and Conference Call Schedule Apr 5, 2004 Osteotech and Smith & Nephew, Inc. Enter Into Private Label DBM Agreement Mar 29, 2004 Stephen Galliker Joins Osteotech Board Mar 2, 2004 Osteotech Reports Fourth Quarter Revenues Increase 29%; Diluted Net Income Per Share Increases to a Record $.37; Issues 2004 Guidance Feb 26, 2004 Osteotech Announces Fourth Quarter 2003 Earnings Release and Conference Call Schedule Feb 9, 2004 Osteotech Announces Domestic Sales and Marketing Organization Changes Jan 16, 2004 Osteotech Terminates Distribution Agreement With SpineVision; Plans Expanded Investment in Franchise Tissue Businesses Jan 5, 2004 Osteotech Announces Publication of an Industry First, Prospective Randomized Clinical Trial With Demineralized Bone Matrix in a Carrier; Grafton(R) DBM Nov 3, 2003 Osteotech Receives Initial $2.5 Million Settlement Payment from GenSci Oct 20, 2003 Osteotech Reports Third Quarter 2003 Results Oct 16, 2003 Osteotech Announces Third Quarter Earnings Release and Conference Call Schedule Oct 3, 2003 Osteotech's October 3, 2003 Conference Call Information Oct 3, 2003 Osteotech Announces Preliminary Third Quarter 2003 Results, Guidance for the Balance of 2003 and Initial Guidance for 2004 Sep 29, 2003 Osteotech Confirms Conference Call on October 3, 2003 and Will Discuss 2003 and 2004 Guidance Sep 26, 2003 Osteotech Announces 5% Workforce Reduction; To Hold Conference Call Aug 15, 2003 Osteotech Operations Not Negatively Affected by Power Failure Jul 25, 2003 Osteotech Reports Second Quarter Revenues of $24.8 Million; Diluted Net Income Per Share of $.15 Jul 21, 2003 Osteotech Announces Second Quarter Earnings Release and Conference Call Schedule Jun 2, 2003 Osteotech Announces Signing Definitive Agreement to Settle Claim Against GenSci Apr 29, 2003 Osteotech Reports First Quarter Revenues of $22.5 Million and Diluted Earnings Per Share of $.07 Apr 22, 2003 Osteotech Announces First Quarter Earnings Release and Conference Call Schedule Apr 21, 2003 Osteotech Announces Agreement in Principle to Settle Claim Against GenSci Mar 4, 2003 Osteotech Reports Fourth Quarter 2002 Results; Confirms First Quarter and Full Year 2003 Guidance Mar 3, 2003 Webcast Alert: Osteotech, Inc. Announces Fourth Quarter and Full Year 2002 Earnings Conference Call Webcast Feb 28, 2003 Osteotech Announces Fourth Quarter 2002 Earnings Release and Conference Call Schedule Feb 3, 2003 Osteotech Enters Into Exclusive Distribution Agreement With SpineVision Dec 19, 2002 Osteotech Provides Guidance for Balance of 2002 and Guidance for 2003; Completes Return to Normal Processing Schedule Dec 19, 2002 Webcast Alert: Osteotech, Inc. Announces Conference Call Webcast Dec 17, 2002 Osteotech Announces Agreement With DePuy Orthopaedics, DePuy Acromed and LifeNet to Provide Private Label DBM Carrier Product to Hospital Market Oct 29, 2002 Osteotech Reports Third Quarter 2002 Results; Revenues Increased 3% and Net Income Increases 334% Oct 25, 2002 Osteotech Announces Third Quarter 2002 Earnings Release and Conference Call Schedule Oct 15, 2002 Osteotech Announces Restart of Processing Operations and Estimated Impact of the Processing Halt on Third Quarter 2002 Results Oct 7, 2002 Osteotech Announces Completion of FDA Inspection; Resumption of Tissue Processing on Schedule Oct 3, 2002 Osteotech Reports On October 1st Conference Call Sep 30, 2002 Osteotech Temporarily Suspends Certain Tissue Processing Operations And Initiates Voluntary Retrieval of Tissue Jul 31, 2002 Osteotech Reports Revenues Increase 21% and Diluted Net Income Per Share Increases $.17 to $.02 in Second Quarter Jul 25, 2002 Osteotech Announces Second Quarter Earnings Release And Conference Call Schedule Jul 24, 2002 Osteotech Sells Operations of CAM Implants, BV for $2.5 Million Jul 8, 2002 Osteotech Subsidiary and DePuy International, Ltd. Sign Marketing Agreements for Grafton(R) DBM in Key European Markets Jun 25, 2002 Osteotech Completes Settlement of All Outstanding Bone Dowel Patent Lawsuits Jun 18, 2002 Osteotech Settles Lawsuit With Wright Medical Technology Jun 7, 2002 Osteotech Enters Into New Long-Term Processing Agreement With MTF and Settles Patent Lawsuit with MTF and Synthes May 17, 2002 Osteotech Completes Sale of 2.8 Million Shares of Its Common Stock May 9, 2002 Osteotech to Sell Common Stock in a Private Placement Transaction Apr 30, 2002 Osteotech Settles Patent Lawsuit and Sells PolyActive(TM) Patents In Separate Transaction Apr 19, 2002 Osteotech Reports Strong First Quarter Revenues Increase 26%, Returns To Profitability Apr 17, 2002 Osteotech Announces First Quarter Earnings Release And Conference Call Schedule Apr 1, 2002 Osteotech Subsidiary Establishes Tissue Recovery Program In Bulgaria For European Markets Mar 18, 2002 Osteotech Reports Fourth Quarter 2001 and Full Year Results Mar 14, 2002 Osteotech Announces Fourth Quarter 2001 And Full Year Earnings Release And Conference Call Schedule Jan 8, 2002 Osteotech Announces New Tissue Resources and Marketing Agreement With LifeNet Dec 12, 2001 Osteotech Awarded Damages In Its Patent Infringement Lawsuit Against GenSci Nov 30, 2001 Osteotech Patents Declared Valid at GenSci Trial; GenSci Found to Infringe Both Patents Nov 15, 2001 Osteotech Announces Alfaro Departure Nov 8, 2001 Osteotech Provides Progress Report on Patent Lawsuit Trial With GenSci Oct 24, 2001 Osteotech Announces New Breakthrough Technology Oct 23, 2001 Osteotech Reports 10% Revenue Growth in Third Quarter Oct 17, 2001 Osteotech Announces Third Quarter 2001 Earnings Release and Conference Call Schedule Jul 31, 2001 Osteotech Reports Second Quarter 2001 Results Jul 26, 2001 Osteotech Announces Second Quarter 2001 Earnings Release And Conference Call Schedule May 16, 2001 Osteotech Announces Favorable Ruling by the United States Court of Appeals For The Federal Circuit in Its Patent Suit Against GenSci Apr 26, 2001 Osteotech Reports First Quarter Results Apr 23, 2001 Osteotech Announces First Quarter 2001 Results Release and Conference Call Webcast Apr 16, 2001 Osteotech Announces Favorable Ruling in Patent Suit Against GenSci Feb 23, 2001 Osteotech Announces New, Multiple Product, Spinal Implant Distribution Agreement Feb 15, 2001 Osteotech Announces Fourth Quarter 2000 and Full Year Results Release and Conference Call Webcast Jan 16, 2001 Osteotech Announces FDA 510(k) Clearance of Vertebral Body Replacement Device Dec 12, 2000 Federal Court Upholds Osteotech's Patent Interpretation in Case Against GenSci Oct 24, 2000 Osteotech Announces Third Quarter Results in Line With Previously Announced Expectations Oct 23, 2000 Osteotech Announces Third Quarter 2000 Earnings Release And Conference Call Schedule Oct 18, 2000 Osteotech Announces New Patent Lawsuit Sep 28, 2000 Osteotech Expects Third Quarter 2000 Results To Fall Below Analysts' Consensus Estimates Sep 11, 2000 Osteotech and MTF Enter Into New Five-Year Agreement Jul 25, 2000 Osteotech Reports Second Quarter Results Jun 7, 2000 Osteotech Contracts With New Tissue Bank Client May 30, 2000 Osteotech Appoints Steven Annunziato as Vice President of Marketing May 17, 2000 Osteotech Announces Stock Repurchase Program May 2, 2000 Osteotech Announces New Sales Force Initiative Apr 25, 2000 Osteotech Reports First Quarter Results Apr 18, 2000 Osteotech Announces Litigation Progress Against GenSci Feb 14, 2000 Osteotech and Spinal Concepts Enter Into Clinical Research and Co-Promotion Agreement Feb 9, 2000 Osteotech Reports Fourth Quarter and 1999 Results Revenues Increase 22% in Quarter and 28% in the Year Feb 4, 2000 Osteotech Receives French Government `Invest in France Biotechnology Award' Nov 29, 1999 Osteotech Announces Fourth Quarter Expectations Nov 15, 1999 Osteotech Receives $2 Million Settlement Payment from DePuy; Quarterly Recognition Of Payment Clarified Nov 10, 1999 Osteotech Settles Claims Against DePuy in Patent Infringement Suit Nov 8, 1999 Osteotech Announces Departure of Stikeleather Oct 27, 1999 Osteotech Confirms Previously Announced Third Quarter Results Sep 27, 1999 Osteotech Indicates That Third Quarter 1999 Results Will Not Meet Analysts Consensus Estimates Sep 13, 1999 Osteotech Announces New Executive Organization Aug 4, 1999 Osteotech Reports New Patent Suit Jul 20, 1999 Osteotech Reports 29% Revenue Increase in Second Quarter of 1999; Net Income Increases 38% Jun 24, 1999 Osteotech Acquires Versalok(R) Low Back Fixation System Apr 28, 1999 Osteotech First Quarter Revenues Increase 39% and Net Income Increases 50% Apr 14, 1999 Osteotech Announces Development in Lawsuit Against GenSci Mar 3, 1999 Osteotech Confirms It Has Been Named in a Patent Infringement Suit Related to Its Bone Dowel Product Feb 18, 1999 Osteotech Announces 3 for 2 Stock Split Feb 2, 1999 Osteotech Completes Majority Interest Acquisition of OST Developpement SA Jan 22, 1999 Osteotech Reports Record 1998 Results; Revenues Increase 32% and Net Income Increases 81% Dec 10, 1998 Osteotech Issued Patent on Positive Pressure Flow System; Viral Inactivation Plus Bone Impregnation Covered Oct 20, 1998 Osteotech Reports 63% Earnings Increase in Third Quarter Sep 14, 1998 Osteotech Amends GenSci Patent Infringement Suit Adds DePuy, Inc. and DePuy Motech, Inc. Jul 20, 1998 Osteotech Reports Second Quarter Revenues Increased 43%; Net Income Increased 73% Jul 2, 1998 Osteotech Announces Acquisition of OST Developpement SA; Major Initiative Underway to Expand European Allograft Business Jun 26, 1998 Osteotech Announces $5 Million Stock Repurchase Program; Extremely Confident of Meeting Analysts' Expectations for Second Quarter, 1998 Apr 22, 1998 Osteotech Reports Record First Quarter Revenue and Earnings Feb 2, 1998 Osteotech Files Patent Infringement Suit Jan 27, 1998 Osteotech Announces Record Fourth Quarter and Record Full Year 1997 Results; Earnings Exceed Analysts' Expectations Jan 12, 1998 Osteotech Receives U.S. Patent for Unique Method of Producing Spherical Hydroxyapatite Particles Nov 12, 1997 Osteotech Announces Exclusive Ceramic Material Supply Agreement With Convatec Oct 21, 1997 Osteotech Reports 32% Revenue Increase and Net Income Increase of 541% in Third Quarter Jul 16, 1997 Osteotech Reports Record Second Quarter Revenues; Net Income Increases 595% In The Quarter Jun 30, 1997 Osteotech Licenses Out Its Polyactive(TM) Polymer Material Technology Apr 17, 1997 Osteotech Reports Record First Quarter Revenues; Net Income Increases 387% Apr 3, 1997 Osteotech Obtains Consent Injunction Against Biosystems of New England Mar 27, 1997 Osteotech And Musculoskeletal Transplant Foundation Sign New Five Year Agreement